Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue
This Editorial introduces the Special Issue on the efficacy and safety of current treatment strategies for patients with connective tissue disease-related interstitial lung disease, including the use of immunosuppressants, such as cyclophosphamide, mycophenolate mofetil and rituximab, and antifibrot...
Main Authors: | Gian Luca Erre, Arduino Aleksander Mangoni |
---|---|
Format: | Article |
Language: | English |
Published: |
BioExcel Publishing Ltd
2021-01-01
|
Series: | Drugs in Context |
Subjects: | |
Online Access: | https://www.drugsincontext.com/current-therapeutic-strategies-in-connective-tissue-disease-related-interstitial-lung-disease:-introduction-to-the-special-issue |
Similar Items
-
Recent advances in the treatment of systemic sclerosis associated interstitial lung disease
by: Antoniya Kamenova, et al.
Published: (2023-03-01) -
Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications
by: Gian Luca Erre, et al.
Published: (2021-01-01) -
Efficacy, Safety, and Tolerability of Treatments for Systemic Sclerosis-Related Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis
by: Gian Luca Erre, et al.
Published: (2020-08-01) -
Systemic Sclerosis Associated Interstitial Lung Disease: New Directions in Disease Management
by: Mehdi Mirsaeidi, et al.
Published: (2019-10-01) -
Mycophenolate mofetil versus cyclophosphamide plus in patients with connective tissue disease-associated interstitial lung disease: Efficacy and safety analysis
by: Wang Pengfei, et al.
Published: (2023-11-01)